Roger E. McLendon
- Genetics top 0.01%
- Glioma Diagnosis and Treatment 181
- Cancer Research top 0.02%
- Cancer, Hypoxia, and Metabolism 22
- Oncology top 0.05%
- Cancer Cells and Metastasis 21
- Molecular Biology top 0.05%
- Chromatin Remodeling and Cancer 19
- Immunology top 0.2%
-
- Neuroblastoma Research and Treatments 44
-
- Brain Metastases and Treatment 39
-
- Radiopharmaceutical Chemistry and Applications 28
-
- Meningioma and schwannoma management 23
- Co-authors
- Darell D. BignerJeremy N. RichAnita B. HjelmelandHenry S. FriedmanAllan H. FriedmanShideng BaoQiulian WuQing Shi
- Cited by
- GeneticsCancer ResearchOncology
- Journals
- Neuro-Oncology (26 papers)Journal of Neuro-Oncology (20 papers)Journal of Clinical Oncology (19 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Roger E. McLendon
321 papers receiving 41.3k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Genetics 18.7k
- Cancer Research 11.8k
- Oncology 12.9k
- Molecular Biology 19.5k
- Immunology 5.3k
Countries citing papers authored by Roger E. McLendon
This map shows the geographic impact of Roger E. McLendon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger E. McLendon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger E. McLendon more than expected).
Fields of papers citing papers by Roger E. McLendon
This network shows the impact of papers produced by Roger E. McLendon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger E. McLendon. The network helps show where Roger E. McLendon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roger E. McLendon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | 2018 | 38 | |
| 3 | 2017 | 33 | |
| 4 | 2017 | 31 | |
| 5 | 2017 | 33 | |
| 6 | 2017 | 97 | |
| 7 | 2017 | 242 | |
| 8 | A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivobreakdown → | 2016 | 462 |
| 9 | 2015 | 87 | |
| 10 | 2013 | 58 | |
| 11 | 2013 | 91 | |
| 12 | 2012 | 33 | |
| 13 | 2012 | 98 | |
| 14 | 2011 | 370 | |
| 15 | Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastomabreakdown → | 2010 | 613 |
| 16 | 2009 | 53 | |
| 17 | 2009 | 80 | |
| 18 | 2008 | 327 | |
| 19 | Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factorbreakdown → | 2006 | 1022 |
| 20 | 2005 | 257 |
About Roger E. McLendon
Roger E. McLendon is a scholar working on Genetics, Neurology, Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 330 papers that have together received 42.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (181 papers), Neuroblastoma Research and Treatments (44 papers), Brain Metastases and Treatment (39 papers), Radiopharmaceutical Chemistry and Applications (28 papers), Meningioma and schwannoma management (23 papers), Cancer, Hypoxia, and Metabolism (22 papers), Cancer Cells and Metastasis (21 papers) and Chromatin Remodeling and Cancer (19 papers). The work is most often cited by research in Genetics (18.7k citations), Cancer Research (11.8k citations), Oncology (12.9k citations), Molecular Biology (19.5k citations) and Immunology (5.3k citations). Roger E. McLendon has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Darell D. Bigner, Jeremy N. Rich, Anita B. Hjelmeland, Henry S. Friedman, Allan H. Friedman, Shideng Bao, Qiulian Wu, Qing Shi, James E. Herndon and David A. Reardon. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Journal of Clinical Oncology, Cancer and Archives of Pathology & Laboratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.